|
|
Article: Pyro Pharmaceuticals, Inc. Discloses Information on its Ten Patent Applications.
- Article from:
- Biotech Week
- Article date:
- November 11, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Fero Industries, Inc. (OTCBB: FROI) (the "Company") is pleased to provide certain disclosures relating to the ten pending patent applications of Pyro Pharmaceuticals, Inc. As previously announced, the Company has initiated the process of acquiring Pyro Pharmaceuticals, Inc. through an exchange of Pyro's capital stock for shares of the Company's common stock, with Fero remaining as the parent entity and Pyro as a subsidiary. The acquisition of Pyro is expected to close by November 30, 2009 (see also Fero Industries, Inc.).
Alan M. Schechter, Chairman and CEO of Pyro Pharmaceuticals, Inc, was quoted as saying, "Pyro looks forward to completing the business ...
Related newspaper, magazine, and journal articles:
|
|
Article: Fero Industries to Purchases Pyro Pharmaceuticals.
Health & Beauty Close-Up;
October 21, 2009 ;
595 words
... ... Definitive Agreement to acquire Pyro Pharmaceuticals, Inc. of Irvine, California ... the Company noted that Pyro Pharmaceuticals, Inc. is engaged in the ... and Exchange Commission. Pyro Pharmaceuticals, Inc. is developing therapeutics ...
|
|